Preview

Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Efficacy of botulinum toxin in a patient with neurogenic detrusor overactivity

https://doi.org/10.21508/1027-4065-2022-67-4-108-114

Abstract

Neurogenic detrusor overactivity is a dangerin terms of the formation of vesicoureteralreflux, pyelonephritis, and chronic kidney disease. The standard treatment for neurogenic detrusor overactivity is intermittent catheterization of the bladder in combination with M-cholinoblockers, which is not always sufficient. In the article, the authors briefly outlined the physiological basis of intradetrusor injections of botulinum toxin in neurogenic detrusor overactivity in patients with myelodysplasia who underwent surgery for spinal hernias, tumors of the spinal canal, as well as patients with spinal trauma. The technology of intradetrusor injections of botulinum toxin is shown, possible complications are described. The effectiveness of intradetrusor injections of botulinum toxin is shown by a specific clinical example — a description of the medical history of a child who has a history of surgical treatment for a spinal hernia in the newborn period. After the operation, neurogenic detrusor overactivity was revealed, insensitive to treatment with M-cholinoblockers. Complications were vesicoureteral reflux and recurrent pyelonephritis. The results of cystometry before and after double administration of botulinum toxin are shown. Detrusor hypertension was stopped, pyelonephritis remission was achieved, trabecularity of the bladder mucosa was stopped. Simultaneously with the introduction of botulinum toxin, endoscopic correction of vesicoureteral reflux was performed. 

About the Authors

S. S. Nikitin
Petrozavodsk State University, Medical Institute; GrigovichChildren’s Republican Hospital
Russian Federation

Petrozavodsk



N. B. Guseva
Pirogov Russian National Research Medical University; SperanskyChildren’s City Clinical Hospital No. 9; Russian Medical Academy of Continuing Professional Education
Russian Federation

Moscow



M. A. Romashin
Pirogov Russian National Research Medical University; SperanskyChildren’s City Clinical Hospital No. 9
Russian Federation

Moscow



References

1. Chen J.-L., Kuo H.-C. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis. Investig Clin Urol 2020; 61(1): 33-42. DOI: 10.4111/icu.2020.61.S1.S33

2. Wu S.-Y., Chang S.-J., Yang S.S.-D., Hsu C.-K. Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review. Toxins 2021; 13: 447. DOI: 10.3390/toxins13070447

3. Badawi J.K. Botulinum toxin therapy in children with neurogenic detrusor overactivity. Turk J Urol 2020; 46(1): 2-12. DOI: 10.5152/tud.2019.19070

4. Kroll P., Jankowski A., Soltysiak J., Murias M., Skrzypczak M., Zachwieja J. Botulinum toxin-A injections in children with neurogenic bladder. Nephro Urol Mon 2011; 3: 125-128

5. Naqvi S., Clothier J., Wright A., Garriboli M. Urodynamic Outcomes in Children after Single and Multiple Injections for Overactive and Low Compliance Neurogenic Bladder Treated with Abobotulinum Toxin. A J Urol 2020: 203; 413-419. DOI: 10.1097/JU.0000000000000540

6. Menovshhikova L.B., Nikolaev S.N., Kovarskij S.L., Lazishvili M.N., Skljarova T.A. The possibilities of botulinum therapy in children with myelodysplasia and dysfunctional urination. Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii 2020; 10:103. (in Russ.)

7. Osipov I.B., Sarychev S.A., Shhedrina A. Ju., Sosnin E.V., Lebedev D.A., Osipov A.I. Surgical methods of treatment of disorders of the accumulative function of the bladder in children and adolescents with myelodysplasia. Pediatrija 2016; 95(5): 41-47. (in Russ.)

8. Nikitin S.S., Lisicyna N.A. Duration of chemodenervation of the bladder after botulinum toxin injections in patients with spinal neurogenic bladder. Actual problems of pediatrics. XI Congress of Pediatricians of Russia. Collection of materials. Moscow, 2021; 143. (in Russ )

9. Kajbafzadeh A.M., Sharifi-Rad L., Ladi-Seyedian S.S. Intravesical electromotive botulinum toxin type A administration for management of concomitant neuropathic bowel and bladder dysfunction. Int J Colorectal Dis 2016; 31: 1397-1399. DOI: 10.1007/s00384-016-2514-9

10. Ladi-Seyedian S.S., Sharifi-Rad L., Kajbafzadeh A.M. Intravesical electromotive botulinum toxin type “A” administration for management of urinary incontinence secondary to neuropathic detrusor overactivity in children: long-term follow-up. Urology 2018; 114: 167-174. DOI: 10.1016/j.urology.2017.11.039

11. Rudin Yu.Je., Sokolov Yu.Yu., Rudin A.Ju., Maruhnenko D.V., Runenko V.I., Kirsanov A.S. et al. Delayed primary closure of the bladder in children with exstrophy and microcystis. Jeksperimental’naja i klinicheskaja urologija 2020; 4: 146-154. (in Russ.) DOI: 10.29188/2222- 8543-2020-13-4-146-154

12. Safari S., Jamali S., Habibollahi P., Arshadi H., Nejat F., Kajbafzadeh A.M. Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods. Urology 2010; 76: 225-230. DOI: 10.1016/j.urology.2009.09.087

13. Hascoet, J., Peyronnet B., Forin V., Baron M., Capon G., Prudhomme T. et al. Intra-Detrusor Injections of Botulinum Toxin Type a in Children with Spina Bifida: A Multicenter Study. Urology 2018; 116: 161-167. DOI: 10.1016/j.urology.2018.02.033

14. Romashin M.A., Guseva N.B., Mlynchik E.V., Ignat’ev R.O. The use of botulinum toxin type A in pediatric urological practice: the present state of the problem and future prospects. Pediatrija. Consilium Medicum 2021; 1: 72-75. (in Russ.) DOI: 10.26442/26586630.2021.1.200699

15. Dasgupta P. Volume matters: bladder injections of botulinum toxin type A. Eur Urol 2012; 61: 1185-1186. DOI: 10.1016/j.eururo.2012.02.043

16. Saljukov R.V., Kolmakov A.S., Martov A.G. Onabotulinotoxin in the treatment of detrusor hyperactivity in patients with spinal cord injury (literature review). Consilium Medicum 2019; 21 (7): 58-63. (in Russ.) DOI: 10.26442/20751753.2019.7.190386


Review

For citations:


Nikitin S.S., Guseva N.B., Romashin M.A. Efficacy of botulinum toxin in a patient with neurogenic detrusor overactivity. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(4):108-114. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-4-108-114

Views: 450


ISSN 1027-4065 (Print)
ISSN 2500-2228 (Online)